Article Details

Viking Therapeutics begins VK2735 Phase II trial for obesity treatment

Retrieved on: 2025-01-09 18:22:32

Tags for this article:

Click the tags to see associated articles and topics

Viking Therapeutics begins VK2735 Phase II trial for obesity treatment. View article details on hiswai:

Excerpt

Data Insights. The gold standard of business intelligence. Find out more. Approximately 280 adults who are overweight or obese ...

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo